VCA (WOOF) : The total negative money flow of $6.49 million on Tuesday indicates selling on strength. The inflow of money on upticks was $10.95 million, compared to $17.43 million outflow on downticks, which confirms distribution in the stock. The up to down ratio was 0.63. The negative money flow of $7.71 million in block trades reveals that the informed traders sold the stock on every bit of price strength. The traded value of the stock on uptick was $3.18 million in a block trade.The transaction value of block trade on downtick was $10.9 million. The uptick to downtick ratio was 0.29. The price action in the VCA (WOOF) stock suggests that both the bulls and the bears were in equilibrium. The stock traded at $69.12 with a gain of $0.56 , a change of 0.82% over the previous days close. The stock registered 1.01% for the week.
The company Insiders own 4.6% of VCA shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -21.87% . Institutional Investors own 91.12% of VCA shares. During last six month period, the net percent change held by insiders has seen a change of -21.87%. In an insider trading activity,The officer (President, Antech Diagnostics) of Vca Inc, Drake Josh sold 2,091 shares at $66.05 on June 8, 2016. The Insider selling transaction had a total value worth of $138,111. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Shares of VCA Inc. rose by 3.94% in the last five trading days and 6.6% for the last 4 weeks. VCA Inc. is up 17.75% in the last 3-month period. Year-to-Date the stock performance stands at 25.67%.
VCA (NASDAQ:WOOF): stock turned positive on Tuesday. Though the stock opened at $69.25, the bulls momentum made the stock top out at $69.44 level for the day. The stock recorded a low of $68.8 and closed the trading day at $69.12, in the green by 0.82%. The total traded volume for the day was 843,558. The stock had closed at $68.56 in the previous days trading.
VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Companys animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Companys communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Companys network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.